title: Health Care Utilization and Cost Comparison Between Adherent Hypertension Patients Treated by Single Exforge HCT and Amlodipine/Valsartan/Hydrochlorothiazide Free Combination.
authors.affiliation: Beijing Novartis Pharma Co. Ltd., Shanghai, China.
authors.forename: W
authors.initials: W
authors.lastname: Chen
authors.affiliation: Beijing Novartis Pharma Co. Ltd., Shanghai, China.
authors.forename: Z
authors.initials: Z
authors.lastname: Wei
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: S H
authors.initials: SH
authors.lastname: Ong
authors.affiliation: Novartis Argentina SA, Buenos Aires, Argentina.
authors.forename: G
authors.initials: G
authors.lastname: Machnicki
authors.affiliation: Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
authors.forename: K
authors.initials: K
authors.lastname: Kristijan